| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/30/1996 | US5512436 Polystyrenesulfonic acid |
| 04/30/1996 | US5512433 Methods and compounds for labeling DNA with xanthine and lower alkyl substituted xanthine derivatives and reagents for the in situ detection of chromosomes |
| 04/30/1996 | US5512431 Methods of screening for nucleoside analogs that are incorporated by HIV reverse transcriptase and cause incorrect base pairing |
| 04/30/1996 | US5512430 Diagnostic array for virus infection |
| 04/30/1996 | US5512429 Removing albumin from sample; incubating to release fatty acid; binding to fatty acid binding protein |
| 04/30/1996 | US5512304 Method of preparing a thromboplastin extract |
| 04/30/1996 | US5512159 Biosensor |
| 04/25/1996 | WO1996012191A1 STABILISING MEDIUM FOR αGST IN URINE FOR USE IN AN ENZYME IMMUNOASSAY |
| 04/25/1996 | WO1996012190A2 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
| 04/25/1996 | WO1996012184A1 Diagnosis and monitoring process, and medicaments for the therapy of states of shock in human beings |
| 04/25/1996 | WO1996012043A1 Method for accurate counting of probe spots in cell nuclei |
| 04/25/1996 | WO1996012042A2 Dna polymerases having modified nucleotide binding site for dna sequencing |
| 04/25/1996 | WO1996012041A1 Improved method for nucleotide sequence amplification |
| 04/25/1996 | WO1996012040A2 Compositions and methods for the detection of chlamydia trachomatis |
| 04/25/1996 | WO1996012039A1 Massively parallel sequencing of sorted polynucleotides |
| 04/25/1996 | WO1996012038A1 Method of monitoring endospore-forming bacteria |
| 04/25/1996 | WO1996012037A1 Method for analysing a cell cluster |
| 04/25/1996 | WO1996012036A1 Automated system and method for estimating antibiotic effectiveness from drug diffusion tests |
| 04/25/1996 | WO1996012033A1 Polycystic kidney disease gene |
| 04/25/1996 | WO1996012025A1 TRANSGENIC NONHUMAN ANIMAL HAVING FUNCTIONALLY DISRUPTED INTERLEUKIN-1β CONVERTING ENZYME GENE |
| 04/25/1996 | WO1996012024A1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 04/25/1996 | WO1996012019A2 Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family |
| 04/25/1996 | WO1996012018A2 Novel immunophilins and corresponding nucleic acids |
| 04/25/1996 | WO1996012017A1 Gene participating in apoptosis |
| 04/25/1996 | WO1996012016A1 Neuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophy |
| 04/25/1996 | WO1996012014A1 Molecular tagging system |
| 04/25/1996 | WO1996012011A1 Reporter cell line |
| 04/25/1996 | WO1996012007A1 Stable recombinant hcmv protease |
| 04/25/1996 | WO1996011937A1 Porphyrin labeling of polynucleotides |
| 04/25/1996 | WO1995035377A3 Materials and methods for detection of oxalate |
| 04/25/1996 | CA2441634A1 Molecular tagging system |
| 04/25/1996 | CA2208256A1 Method for accurate counting of probe spots in cell nuclei |
| 04/25/1996 | CA2202680A1 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
| 04/25/1996 | CA2202628A1 Apoptosis-associated gene |
| 04/25/1996 | CA2202533A1 Her4 human receptor tyrosine kinase |
| 04/25/1996 | CA2202480A1 Porphyrin labeling of polynucleotides |
| 04/25/1996 | CA2202465A1 Process for the diagnostic assessment and monitoring, as well as medicaments for the therapy of states of shock in humans |
| 04/25/1996 | CA2202283A1 Polycystic kidney disease gene |
| 04/24/1996 | EP0708178A1 Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy |
| 04/24/1996 | EP0707660A1 Method for generation of sequence sampled maps of complex genomes |
| 04/24/1996 | EP0707659A1 Salmonella identification by the polymerase chain reaction |
| 04/24/1996 | EP0707658A1 Liquid stable thiol activator |
| 04/24/1996 | EP0707657A1 Enzymatic preparation of monic acids |
| 04/24/1996 | EP0707652A1 Dna coding for a peptide of a papilloma virus main capside protein and use thereof |
| 04/24/1996 | EP0707651A1 METHODS AND COMPOSITIONS FOR DETECTION OF $i(SALMONELLA) |
| 04/24/1996 | EP0707649A1 Cisplatin resistance gene and uses therefor |
| 04/24/1996 | EP0707648A1 Platelet glycoprotein v gene and uses |
| 04/24/1996 | EP0707647A1 Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis |
| 04/24/1996 | EP0707644A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 04/24/1996 | EP0707635A1 Direct and biochemically functional detection process of retrovirus in biological samples |
| 04/24/1996 | EP0707496A1 METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN inhA GENE |
| 04/24/1996 | EP0707493A1 Inhibitors and target molecule co-localization |
| 04/24/1996 | EP0550693B1 Direct cloning of pcr amplified nucleic acids |
| 04/24/1996 | EP0490951B1 Fragments of nucleic acids derived from an appropriate mycobacteria genome, their applications in the diagnosis of mycobateria infections and plasmides containing said fragments |
| 04/23/1996 | US5510475 Attachment of reporters by way of phosphonamidate linkers, having protected hydroxyl or amino functionality |
| 04/23/1996 | US5510473 Cloning of the recA gene from thermus aquaticus YT-1 |
| 04/23/1996 | US5510270 Generating pattern of light and dark areas by selectively irradiating surface areas; deprotecting; contacting with receptor to identify oligonucleotide showing complementarity to receptor |
| 04/23/1996 | US5510259 Isolated, purified dna having nucleotide sequence coding for said molecule |
| 04/23/1996 | US5510246 Detecting early changes in specified indicia of colony growth |
| 04/23/1996 | US5510245 Composition and method of assaying for ketone bodies |
| 04/23/1996 | US5510244 Apparatus and method for assaying optical isomers |
| 04/23/1996 | US5510243 Colorimetric analysis |
| 04/23/1996 | US5510241 Using monoclonal antibodies |
| 04/23/1996 | US5510240 Method of screening a peptide library |
| 04/23/1996 | US5510099 Exposing transgenic mouse to test agent, recovering sample of test dna sequence, determining frequency of mutation by bioassay in prolysogenic escherichia coli |
| 04/23/1996 | US5510084 Process for immobilizing a nucleic acid fragment by passive attachment to a solid substrate, the solid substrate thus obtained, and its use |
| 04/23/1996 | US5509410 Strip electrode including screen printing of a single layer |
| 04/23/1996 | CA2073546C Stabilized creatine kinase control or calibration fluid |
| 04/19/1996 | CA2138425A1 Neuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophy |
| 04/18/1996 | WO1996011448A1 Improved accuracy in cell mitosis analysis |
| 04/18/1996 | WO1996011406A1 Apparatus and method for storage, purification or reaction and processing of a biopolymer |
| 04/18/1996 | WO1996011402A1 Biosensor with biomaterial covalently fixed on a signal-active surface |
| 04/18/1996 | WO1996011283A1 Compositions and methods for detection of 2,4-dichlorophenoxyacetic acid and related compounds |
| 04/18/1996 | WO1996011280A1 Attenuated viruses and method of making the same |
| 04/18/1996 | WO1996011276A1 Method, reagent and kit for evaluating susceptibility to premature atherosclerosis and treatment of same using gene therapy |
| 04/18/1996 | WO1996011274A1 Chimeric papillomavirus-like particles |
| 04/18/1996 | WO1996011267A1 Dna coding for a zinc finger protein, a zinc finger protein and the use thereof |
| 04/18/1996 | WO1996011263A1 Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria |
| 04/18/1996 | WO1996011260A1 Patched genes and their use |
| 04/18/1996 | WO1996011258A1 Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same |
| 04/18/1996 | WO1996011257A1 Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same |
| 04/18/1996 | WO1996011211A1 Selective inhibition of internally initiated rna translation |
| 04/18/1996 | WO1996011010A1 Bridged and unbridged quadruplex/duplex oligonucleotides |
| 04/18/1996 | WO1996010911A1 Cytokine designated lerk-6 |
| 04/18/1996 | WO1996007739A3 Interleukin-1 type 3 receptors |
| 04/18/1996 | WO1996003528A3 Oligonucleotides and their use |
| 04/18/1996 | WO1996001317A3 Mammalian peroxisome proliferator-activated receptors and uses thereof |
| 04/18/1996 | DE4436352A1 Verfahren zur diagnostischen Beurteilung und Verlaufskontrolle sowie Arzneimittel zur Therapie von Schockzuständen beim Menschen Method for the diagnostic assessment and monitoring and drugs for the treatment of shock in humans |
| 04/18/1996 | CA2202043A1 Biosensor with biomaterial covalently fixed on a signal-active surface |
| 04/18/1996 | CA2202029A1 Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same |
| 04/18/1996 | CA2202027A1 Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same |
| 04/18/1996 | CA2201868A1 Improved accuracy in cell mitosis analysis |
| 04/18/1996 | CA2201702A1 Selective inhibition of internally initiated rna translation |
| 04/18/1996 | CA2201616A1 Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria |
| 04/18/1996 | CA2201487A1 Attenuated viruses and method of making the same |
| 04/18/1996 | CA2201132A1 Cytokine designated lerk-6 |
| 04/17/1996 | EP0707077A2 Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same |
| 04/17/1996 | EP0707076A1 RNA template end-linked probe constructs and methods for use |
| 04/17/1996 | EP0707075A2 Species-specific detection of Mycobacterium kansasii |
| 04/17/1996 | EP0707074A1 Method for determination of urea nitrogen |